Home  >  Products  >  GBA3 (glucosidase, beta, acid 3 (cytosolic)) Blocking Peptide (the N terminal of GBA3)(100ug)
GBA3 (glucosidase, beta, acid 3 (cytosolic)) Blocking Peptide (the N terminal of GBA3)(100ug)

GBA3 (glucosidase, beta, acid 3 (cytosolic)) Blocking Peptide (the N terminal of GBA3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GBA3 Antibody(ARP57505_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57505
Size: 100ug
Weight: 54kDa
Gene: 57733
Format: Lyophilized powder
Target: GBA3, or cytosolic beta-glucosidase (EC 3.2.1.21), is a predominantly liver enzyme that efficiently hydrolyzes beta-D-glucoside and beta-D-galactoside, but not any known physiologic beta-glycoside, suggesting that it may be involved in detoxification of plant glycosides (de Graaf et al., 2001 [PubMed 11389701]). GBA3 also has significant neutral glycosylceramidase activity (EC 3.2.1.62), suggesting that it may be involved in a nonlysosomal catabolic pathway of glucosylceramide metabolism (Hayashi et al., 2007 [PubMed 17595169]).
Alternative names: CBGL1; GLUC; KLrP; MGC104276; MGC126878
See Full Product Listings >